Kazia Therapeutics Limited
KZIA · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,702 | -$26,778 | -$20,465 | -$25,014 |
| Dep. & Amort. | $934 | $1,869 | $1,869 | $1,869 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $653 | $533 | $1,159 | $1,675 |
| Change in WC | -$3,008 | $10,002 | $4,332 | $862 |
| Other Non-Cash | $8,845 | $4,793 | -$2,051 | -$2,154 |
| Operating Cash Flow | -$13,278 | -$9,581 | -$15,156 | -$22,762 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | -$2,365 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$2,365 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $405 | $0 | $0 |
| Stock Issued | $14,804 | $5,580 | $12,972 | $3,726 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,178 | $0 | $0 | $0 |
| Financing Cash Flow | $15,982 | $5,985 | $12,972 | $3,726 |
| Forex Effect | -$16 | $12 | $64 | $1,175 |
| Net Chg. in Cash | $2,688 | -$3,584 | -$2,120 | -$20,226 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,657 | $5,241 | $7,361 | $27,587 |
| End Cash | $4,345 | $1,657 | $5,241 | $7,361 |
| Free Cash Flow | -$13,278 | -$9,581 | -$15,156 | -$22,762 |